Chia-Yi Chu, PhD, characterized the roles of RANKL-RANK signaling in cancer growth and metastasis. She determines the convergent signaling network between RANK and c-Met that regulates cancer bone colonization.
Dennis Jen-Ming Huang, PhD, is a postdoctoral fellow of medicine at Cedars-Sinai. His research focuses on network analyses of metastatic prostate cancer with focus on molecular mechanisms underlying osteoblastic and osteolytic related gene expression by human prostate cancer cell lines.
Stefan Mrdenovic, MD, is a postdoctoral fellow in the Chung Laboratory. Mrdenovic performs novel anticancer agents testing. He conducts biochemical and molecular analyses of pancreatic circulating tumor cells.
Srinivas Nandana, PhD, is a transgenic mouse expert whose research interest is elucidating T-box transcription factor and RANKL in cancer cell growth, survival and metastasis.
Baiming Sun, BS, performs experiments using laboratory techniques of cell biology and molecular biology. She performs animal surgeries for the Uro-Oncology Research Program.
Ruoxiang Wang, MD, PhD, is an associate professor of medicine at both Cedars-Sinai and UCLA. He characterizes the stem cell phenotypes in prostate cancer cells, defines the fusion between prostate cancer epithelial and prostate stromal cells and explores the use of stem cells as therapeutic targeting agent.